Better understanding of the molecular events that underlie the cause of cancer and disease progression drives advancements in oncology. We support your path to success with a comprehensive range of assays for analysis of genomic variants such as mutations, insertions, deletions and fusions. Our comprehensive portfolio of assays enables rapid and sensitive detection and/or quantification of oncology biomarkers.